Trial site
CHU Grenoble Alpes
- 43running trials
- 12closed trials
- 0trials confirmed by the site in the last 60 days
- –languages not stated
The site has not confirmed any trial yet.
Running trials
Not yet recruiting
Not yet recruiting
Recruiting
Clinical Utility of LIBS Multi-Element Imaging and the IFF Algorithm in Chronic Lung Diseases
Not yet recruiting
Not yet recruiting
Recruiting
The Role of Priors in Hallucinatory Perception in Parkinson's Disease
Recruiting
Recruiting
Recruiting
Alpha Radiation Emitters Device (DaRT) for the Treatment of Locally Advanced Pancreatic Cancer
Recruiting
Recruiting
Recruiting
Recruiting
Impact of the Mylife CamAPS FX System With the DEXCOM G6 Sensor on T1D Patients in France
Not yet recruiting
Recruiting
Not yet recruiting
Not yet recruiting
Dynamic Impact of NIV on Diaphragmatic Ultrasound in Patients With Amyotrophic Lateral Sclerosis
Recruiting
Training of Nursing Home Professionals and Quality of Life of Residents With Parkinson's Disease
Recruiting
Recruiting
Long-term Evaluation of the SIMEOX Device at Home in Non-cystic Fibrosis Bronchiectasis
Recruiting
Recruiting
Recruiting
Recruiting
Cardiac Amyloidosis pRevaleNce of in OLDer Subjects Affected by Heart Failure
Recruiting
FIRST-NEC (GFPC 01-2022) - Combination of Durvalumab With Etoposide and Platinum
Active, not recruiting
Myocardial Effects in Patients With ATTRv With Polyneuropathy Treated With Patisiran or Vutrisiran
Recruiting
Active, not recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Monitoring of the End-tidal Carbon Dioxide (EtCO2) as a Severity Criterion in COPD Exacerbations
Recruiting
Recruiting
Towards the Validation of a New Blood Biomarker for the Early Diagnosis of Parkinson's Disease
Recruiting
MoleculAr Profiling for Pediatric and Young Adult Cancer Treatment Stratification 2
Recruiting
Recruiting
Sensory-Motor Integration for Speech Rehabilitation in Patients With Post-stroke Aphasia
Recruiting
Alpha Radiation Emitters Device (DaRT) for the Treatment of of Malignant Cutaneous Tumors
Active, not recruiting
Recruiting
RESTORE - Study of AGN1 LOEP to Prevent Secondary Hip Fractures
Recruiting
Autoreactive Anti-Ro/SSA IgE To Determine Primary SjögRen's Syndrome's Disease Activity
Recruiting
LIquid BIopsies in Patients Presenting Non-small Cell Lung Cancer
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Parkinson disease4 recruiting
- Liver and biliary tract cancer3 recruiting
- Childhood cancers2 recruiting
- COPD2 recruiting
- Heart failure2 recruiting
- High blood pressure2 recruiting
- Lung cancer2 recruiting
- Melanoma2 recruiting
- Prostate cancer2 recruiting
- Stroke2 recruiting
- Type 1 diabetes2 recruiting
- ALS (motor neurone disease)1 recruiting
- Alzheimer disease1 recruiting
- Amyloidosis1 recruiting
- Atrial fibrillation1 recruiting
- Chronic myeloid leukaemia1 recruiting
- Colorectal cancer1 recruiting
- Crohn's disease1 recruiting
- Cystic fibrosis1 recruiting
- Depression1 recruiting
- Hepatitis B1 recruiting
- Hypertrophic cardiomyopathy1 recruiting
- Metastatic breast cancer1 recruiting
- Multiple sclerosis1 recruiting
- Myeloproliferative neoplasms1 recruiting
- Neuroendocrine tumours1 recruiting
- Osteoporosis1 recruiting
- Pancreatic cancer1 recruiting
- Pulmonary arterial hypertension1 recruiting
- Sarcoma1 recruiting
- Sickle cell disease1 recruiting
- Sjögren's disease1 recruiting
- Ulcerative colitis1 recruiting
Researchers
No researcher is linked here yet.
Closed trials
Completed
Completed
Pulsed Field Ablation vs Cryoablation In Paroxysmal Atrial Fibrillation
Withdrawn
Programmes de Marche Active et qualité de Vie Dans la Maladie de Parkinson
Terminated
Satisfaction of Patients With Amyotrophic Lateral Sclerosis Regarding Home Assisted Teleconsultation
Completed
Completed
An Open, Study to Assess the Safety of RGTA® (OTR4132) in Patients With Acute Ischemic Stroke (AIS)
Completed
Completed
Efficacy Study of a Selective Chest Wall Restriction Belt in Postoperative of Lung Resection
Completed
Study of Early Relapsed, Lenalidomide-refractory Subjects Eligible for Carfilzomib Triplet
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 5 Nov 2026